BRIEF-Pharming Group FY net loss narrows to 5.8 mln euros

* FY revenues from operations increased to 21.2 million euros ($23.4 million) (2013: 6.8 million euros)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.